Literature DB >> 7261478

Ocular and dermal delayed hypersensitivity reactions in guinea-pigs following infection with guinea-pig inclusion conjunctivitis agent (Chlamydia psittaci).

M A Monnickendam, S Darougar, A M Tilbury.   

Abstract

Guinea-pigs which had been sensitized to guinea-pig inclusion conjunctivitis agent by ocular infection, were given ocular and dermal challenges with a range of doses of agent. Ocular delayed-type hypersensitivity responses were elicited by a wide range of doses. Such responses were associated with the presence of chlamydial inclusions and inflammatory cells. The EID50 for ocular reinfection was only slightly higher than that for primary ocular infection. Dermal delayed-type hypersensitivity reactions were produced only when high doses of agent were used. The relevance of these observations to human chlamydial eye disease is discussed.

Entities:  

Mesh:

Year:  1981        PMID: 7261478      PMCID: PMC1537224     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  9 in total

1.  SYMPOSIUM ON TRACHOMA. BIOLOGY OF THE VIRUS.

Authors:  J T GRAYSTON
Journal:  Invest Ophthalmol       Date:  1963-10

2.  Infectivity titration of guinea-pig inclusion conjunctivitis agent in irradiated McCoy cells.

Authors:  M S Griffiths; S Ainsworth; J H Pearce
Journal:  J Gen Microbiol       Date:  1976-08

3.  The prevention of blindness from trachoma.

Authors:  B R Jones
Journal:  Trans Ophthalmol Soc U K       Date:  1975-04

4.  Observations on guinea pig inclusion conjunctivitis agent.

Authors:  F B Gordon; E Weiss; A L Quan; H R Dressler
Journal:  J Infect Dis       Date:  1966-04       Impact factor: 5.226

5.  Results of complement-fixation and intradermal tests for Bedsoniae in genital infection, disease of the eye and Reiter's disease.

Authors:  C F Barwell; E M Dunlop; J W Race
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

6.  Relation of TRIC agent to "non-specific genital infection".

Authors:  E M Dunlop; I A Harper; M K al-Hussaini; J A Garland; J D Treharne; D J Wright; B R Jones
Journal:  Br J Vener Dis       Date:  1966-06

7.  Resistance to reinfection with a chlamydial agent (guinea pig inclusion conjunctivitis agent).

Authors:  A Ahmad; C R Dawson; C Yoneda; B Togni; J Schachter
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-06       Impact factor: 4.799

8.  Development of chronic conjunctivitis with scarring and pannus, resembling trachoma, in guinea-pigs.

Authors:  M A Monnickendam; S Darougar; J D Treharne; A M Tilbury
Journal:  Br J Ophthalmol       Date:  1980-04       Impact factor: 4.638

9.  Guinea-pig inclusion conjunctivitis as a model for the study of trachoma: clinical, microbiological, serological, and cytological studies of primary infection.

Authors:  M A Monnickendam; S Darougar; J D Treharne; A M Tilbury
Journal:  Br J Ophthalmol       Date:  1980-04       Impact factor: 4.638

  9 in total
  4 in total

1.  Responses to tuberculin in the guinea-pig eye as a model of cell mediated immune responses in the external eye.

Authors:  R S Dwyer; S Darougar; M A Monnickendam
Journal:  Br J Ophthalmol       Date:  1987-04       Impact factor: 4.638

2.  Ocular delayed hypersensitivity: a pathogenetic mechanism of chlamydial-conjunctivitis in guinea pigs.

Authors:  N G Watkins; W J Hadlow; A B Moos; H D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

3.  Cross-Reactive Effects of Vaccines: Heterologous Immunity between Tetanus and Chlamydia.

Authors:  Marijana Stojanovic; Ivana Lukic; Emilija Marinkovic; Ana Kovacevic; Radmila Miljkovic; Joshua Tobias; Irma Schabussova; Mario Zlatović; Talin Barisani-Asenbauer; Ursula Wiedermann; Aleksandra Inic-Kanada
Journal:  Vaccines (Basel)       Date:  2020-12-01

4.  Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein.

Authors:  R P Morrison; K Lyng; H D Caldwell
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.